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Evaluation of endothelial cell adhesion molecules and anti-C1q antibody in 
discriminating between active and non-active systemic lupus erythematosus 
ABSTRACT 
Background: Detecting the active state of systemic lupus erythematosus (SLE) is important 
but challenging. This study aimed to determine the diagnostic accuracy of serum endothelial 
cell adhesion molecules (ICAM-1 and VCAM-1) and anti-C1q antibody in discriminating 
between active and non-active SLE. Methods: Using SELENA-SLE disease activity index 
(SLEDAI), 95 SLE patients (45 active and 50 non-active) were assessed. A score above five 
was considered indicative of active SLE. The blood samples were tested for serum ICAM-1, 
VCAM-1 and anti-C1q antibody using enzyme-linked immunosorbent assay (ELISA). 
Results: The levels of serum VCAM-1 and anti-C1q antibody were significantly higher in 
active SLE patients. Both VCAM-1 and anti-C1q were able to discriminate between active 
and non-active SLE (p-value < 0.001 and 0.005, respectively). From the receiver operating 
characteristic curves (ROCs) constructed, the optimal cut-off values for VCAM-1 and anti-
C1q antibody in discriminating between active and non-active SLE were 30.5 ng/mL (69.0% 
sensitivity, 60.0% specificity, PPV 58.5%, NPV 66.7%) and 7.86 U/mL (75.6% sensitivity, 
80% specificity, PPV 77.3%, NPV 78.4%), respectively. However, serum ICAM-1 level was 
unable to discriminate between the two groups (p-value = 0.193). Conclusion: Anti-C1q 
antibody demonstrated the best diagnostic accuracy in discriminating between active and 
non-active SLE patients. 
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